{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:44:32Z","timestamp":1764510272075},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1007\/bf01703444","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T01:08:45Z","timestamp":1118538525000},"page":"206-209","source":"Crossref","is-referenced-by-count":21,"title":["Interferon alpha-2b in the long-term treatment of essential thrombocythemia"],"prefix":"10.1007","volume":"63","author":[{"given":"S.","family":"Sacchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tabilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Messora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Falzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rupoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01703444_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01720201","volume":"60","author":"MJBP Abegg-Werter","year":"1990","unstructured":"Abegg-Werter MJBP, Raemaekers JMM, de Pauw BE, Haanen C (1990) Recombinant interferon-alpha, but not interferon-gamma is effective therapy for essential thrombocythemia. Blut 60: 37\u201340","journal-title":"Blut"},{"key":"BF01703444_CR2","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJM198805193182010","volume":"318","author":"JW Adamson","year":"1988","unstructured":"Adamson JW (1988) Wither the platelet? N Engl J Med 318: 1331\u20131332","journal-title":"N Engl J Med"},{"key":"BF01703444_CR3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830330217","volume":"33","author":"PJ Anker-Lugtenburg van den","year":"1990","unstructured":"Anker-Lugtenburg van den PJ, Sizoo W (1990) Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea. Am J Hematol 33: 152","journal-title":"Am J Hematol"},{"issue":"Suppl 4","key":"BF01703444_CR4","first-page":"1","volume":"27","author":"FR Appelbaum","year":"1990","unstructured":"Appelbaum FR (1990) Introduction and overview of interferon alfa in myeloproliferative and hemangiomatous diseases. Semin Hematol 27 [Suppl 4]: 1\u20135","journal-title":"Semin Hematol"},{"key":"BF01703444_CR5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0140-6736(88)92625-6","volume":"2","author":"S Bellucci","year":"1988","unstructured":"Bellucci S, Harousseau JL, Brice P, Tobelem G (1988) Treatment of essential thrombocythaemia by alpha 2a interferon. Lancet 2: 960\u2013961","journal-title":"Lancet"},{"key":"BF01703444_CR6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.2830170402","volume":"17","author":"PB Donovan","year":"1984","unstructured":"Donovan PB, Kaplan ME, Goldberg JD, Tatarsky I, Najean Y, Silberstein EB, Knospe WH, Laszlo J, Mack K, Berk PD, Wasserman LR (1984) Treatment of polycythemia vera with hydroxyurea. Am J Hematol 17: 329\u2013334","journal-title":"Am J Hematol"},{"key":"BF01703444_CR7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","volume":"58","author":"PJ Fialkow","year":"1981","unstructured":"Fialkow PJ, Faguet GB, Jacobsen RJ, Vaidya K, Murphy S (1981) Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 58: 916\u2013919","journal-title":"Blood"},{"key":"BF01703444_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/77.3.353","volume":"77","author":"SA Geller","year":"1982","unstructured":"Geller SA, Shapiro E (1982) Acute leukemia as a natural sequel to primary thrombocythemia. Am J Clin Pathol 77: 353\u2013356","journal-title":"Am J Clin Pathol"},{"key":"BF01703444_CR9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(88)90005-0","volume":"2","author":"FJ Giles","year":"1988","unstructured":"Giles FJ, Gray AG, Brozovic M, Grant IR, Machin SJ, Richards JDM, Venutas S, Singer CRJ, Yong KL, Davies SC, Hoffbrand AV, Mehta AB, Thomas MJG, Goldstone AH (1988) Alpha-interferon therapy for essential thrombocythaemia. Lancet 2: 70\u201372","journal-title":"Lancet"},{"key":"BF01703444_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/10428199009050983","volume":"3","author":"FJ Giles","year":"1990","unstructured":"Giles FJ, Anderson CC, Grant IR, Hoffbrand AV, Mehta AB, Machin SJ, Goldstone AH (1990) Recombinant alpha 2A interferon: an effective maintenance agent in essential thrombocythaemia. Leukemia Lymphoma 3: 103\u2013107","journal-title":"Leukemia Lymphoma"},{"key":"BF01703444_CR11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0140-6736(89)92142-9","volume":"1","author":"H Gisslinger","year":"1989","unstructured":"Gisslinger H, Linkesch W, Fritz E, Ludwig H, Chott A, Radaszkiewicz TH (1989) Long-term interferon therapy for thrombocytosis in myeloproliferative diseases. Lancet 1: 634\u2013637","journal-title":"Lancet"},{"key":"BF01703444_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajh.2830300112","volume":"30","author":"JC Gris","year":"1989","unstructured":"Gris JC, Schved JF, Arnaud A, Chauvet C (1989) Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with melphalan. Am J Hematol 30: 47\u201354","journal-title":"Am J Hematol"},{"key":"BF01703444_CR13","first-page":"277","volume":"72","author":"L Gugliotta","year":"1987","unstructured":"Gugliotta L, Macchi S, Catani L, Chetti L, Mattioli Belmonte M, Guarini A, Criscuolo D, Tura S (1987) Recombinant alpha-2a interferon in the treatment of essential thrombocythaemia. Preliminary report. Haematologica (Pavia) 72: 277\u2013279","journal-title":"Haematologica (Pavia)"},{"key":"BF01703444_CR14","first-page":"284","volume":"55","author":"H Kasparu","year":"1987","unstructured":"Kasparu H, Reisner R, Bernhart M, Fortelny A, Pittermann E, Krieger O, Lutz D (1987) Recombinant alpha 2b interferon in the treatment of essential thrombocythaemia. Blut 55: 284","journal-title":"Blut"},{"key":"BF01703444_CR15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0609.1990.tb00355.x","volume":"44","author":"J Kutti","year":"1990","unstructured":"Kutti J (1990) The management of thrombocytosis. Eur J Haematol 44: 81\u201388","journal-title":"Eur J Haematol"},{"key":"BF01703444_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.1989.tb07679.x","volume":"72","author":"M Lazzarino","year":"1989","unstructured":"Lazzarino M, Vitale A, Morra E, Gagliardi A, Bernasconi P, Torromeo C, Inverardi D, Burgio V, Castello A, Bernasconi C, Mandelli F (1989) Interferon alpha-2b as treatment for Philadelphia-negative chronic myeloproliferative disorders with excessive thrombocytosis. Br J Haematol 72: 173\u2013177","journal-title":"Br J Haematol"},{"key":"BF01703444_CR17","first-page":"266","volume":"25","author":"H Ludwig","year":"1987","unstructured":"Ludwig H, Linkesch W, Gisslinger H, Fritz E, Sinzinger H, Radaszkiewicz T, Chott A, Flener R, Micksche M (1987) Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders. Can Immunol Immunother 25: 266\u2013273","journal-title":"Can Immunol Immunother"},{"key":"BF01703444_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(89)91446-3","volume":"1","author":"D May","year":"1989","unstructured":"May D, Wandl UB, Niederle N (1989) Treatment of essential thrombocythaemia with interferon alpha-2b. Lancet 1: 96","journal-title":"Lancet"},{"key":"BF01703444_CR19","first-page":"177","volume":"23","author":"S Murphy","year":"1986","unstructured":"Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 23: 177\u2013182","journal-title":"Semin Hematol"},{"key":"BF01703444_CR20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ajh.2830340108","volume":"34","author":"S Nand","year":"1990","unstructured":"Nand S, Messmore H, Gross Fisher S, Bird ML, Schulz W, Fisher RI (1990) Leukemic transformation in polycythemia vera: analysis of risk factors. Am J Hematol 34: 32\u201336","journal-title":"Am J Hematol"},{"key":"BF01703444_CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198611000-00001","volume":"65","author":"SM Sedlacek","year":"1986","unstructured":"Sedlacek SM, Curtis JL, Weintraub J, Levin J (1986) Essential thrombocythemia and leukemic transformation. Medicine 65: 353\u2013364","journal-title":"Medicine"},{"key":"BF01703444_CR22","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1073\/pnas.83.7.2157","volume":"83","author":"RT Schimke","year":"1986","unstructured":"Schimke RT, Sherwood SW, Hill AB, Johnston RN (1986) Overreplication and recombination of DNA in higher eukaryotes: potential consequences and biological implications. Proc Natl Acad Sci USA 83: 2157\u20132161","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 4","key":"BF01703444_CR23","first-page":"6","volume":"27","author":"RT Silver","year":"1990","unstructured":"Silver RT (1990) Interferon in the treatment of myeloproliferative diseases. Semin Hematol 27 [Suppl 4]: 6\u201314","journal-title":"Semin Hematol"},{"key":"BF01703444_CR24","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM198805193182002","volume":"318","author":"MN Silverstein","year":"1988","unstructured":"Silverstein MN, Petitt RM, Solberg LA, Fleming JS, Knight RC, Schacter LP (1988) Anagrelide: a new drug for treating thrombocytosis. N Engl J Med 318: 1292\u20131294","journal-title":"N Engl J Med"},{"key":"BF01703444_CR25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-99-6-789","volume":"99","author":"M Talpaz","year":"1983","unstructured":"Talpaz M, Mavligit G, Keating M, Walters RS, Gutterman JU (1983) Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemia. Ann Intern Med 99: 789\u2013792","journal-title":"Ann Intern Med"},{"key":"BF01703444_CR26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0002-9343(89)90384-7","volume":"86","author":"M Talpaz","year":"1989","unstructured":"Talpaz M, Kurzrock R, Kantarjian H, O'Brien S, Gutterman JU (1989) Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis. Am J Med 86: 554\u2013558","journal-title":"Am J Med"},{"key":"BF01703444_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00320230","volume":"58","author":"A Tichelli","year":"1989","unstructured":"Tichelli A, Gratwohl A, Berger C, Lori A, Wursch A, Dieterle A, Thomssen C, Nissen C, Holdener E, Speck B (1989) Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a. Blut 58: 15\u201319","journal-title":"Blut"},{"key":"BF01703444_CR28","first-page":"719","volume":"2","author":"G Tobelem","year":"1989","unstructured":"Tobelem G (1989) Essential thrombocythaemia. Clin Haematol 2: 719\u2013728","journal-title":"Clin Haematol"},{"issue":"Suppl 1","key":"BF01703444_CR29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000226078","volume":"42","author":"T Velu","year":"1985","unstructured":"Velu T, Delwiche F, Gangji D, Monsiuer R, Flament J, Stryckmans P, Wybran J, Bellens R (1985) Therapeutic effect of human recombinant interferon-alpha-2c in essential thrombocythaemia. Oncology 42 [Suppl 1]: 10\u201314","journal-title":"Oncology"},{"key":"BF01703444_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000205165","volume":"83","author":"H Vinti","year":"1990","unstructured":"Vinti H, Taillan B, Pesce A, Michiels JF, Bayle J, Cassuto JP (1990) Megakaryoblastic transformation of essential thrombocythemia, hypercalcemia and lytic bone lesions. Acta Haematol 83: 53","journal-title":"Acta Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01703444\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:15:59Z","timestamp":1586279759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01703444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["BF01703444"],"URL":"https:\/\/doi.org\/10.1007\/bf01703444","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}